The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Whole brain radiation therapy (WBRT) with or without oral topotecan (TPT) in patients (pts) with non-small cell lung cancer (NSCLC) with brain metastases: Final analysis of an open-label phase III study.
Rodryg Ramlau
Honoraria - GlaxoSmithKline
Research Funding - GlaxoSmithKline
Jacek Jassem
Research Funding - GlaxoSmithKline
Zsolt Papai-Szekely
No relevant relationships to disclose
Pierre Chabot
No relevant relationships to disclose
Philippe Legenne
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Jeremey Levin
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Jadwiga Sherlock
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Stephen R. Lane
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
John J Brennan
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Tracey Sessa
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Paul Stephen Wissel
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Philip Bonomi
Consultant or Advisory Role - GlaxoSmithKline
Honoraria - GlaxoSmithKline
Research Funding - GlaxoSmithKline